Privacy Policy

Login

Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

Intresserad av platformen MFN för nyhetsdistribution?

Lördag 12 Juli | 03:50:25 Europe / Stockholm

Svenska | English

BioStock

Prenumeration

BioStock: CombiGene's CEO comments on the patent approvals in Australia and India

2024-03-20 08:45:32

CombiGene was granted patents in Australia and India for the CG01 epilepsy project, and the objection period recently passed. BioStock spoke with CEO Peter Ekolind, who believes that this strengthens the project and increases the value ahead of a potential partnership.

Read the full interview with Peter Ekolind at biostock.se:

https://www.biostock.se/en/2024/03/combigenes-ceo-comments-on-the-patent-approvals-in-australia-and-india/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

BioStock

Prenumeration

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden